{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:28:29Z","timestamp":1785191309092,"version":"3.55.0"},"reference-count":48,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Sao Paulo Research Foundation","award":["14\/03989-6"],"award-info":[{"award-number":["14\/03989-6"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Adrenocortical cancer (ACC) is rare and aggressive, with YAP1 overexpression associated with poor outcomes in pediatric patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>In this study, we investigated the mechanisms by which YAP1 drives ACC progression and explored it as a potential target therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>YAP1 expression and methylation in ACC were analyzed from pediatric and adult cohorts. The role of YAP1 on ACC progression was examined in vitro using an adrenocortical cell line. Also, was evaluated the YAP1's influence on \u03b2-catenin. The effect of YAP1 pharmacological inhibition was assessed on tumor growth in a murine xenograft model of ACC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>High YAP1 expression was associated with lower survival in all cohorts. The YAP1 methylation signature was associated with patients\u2019 prognosis. Inhibition of YAP1 reduced ACC cell viability through cell cycle arrest in the G0\/G1 phase, and inhibited the epithelial\u2013mesenchymal transition and cell invasion. YAP1 modulated \u03b2-catenin protein levels and transcription activity, whereas \u03b2-catenin partially mediated the effect of YAP1 on adrenocortical tumorigenesis. In vivo, verteporfin impaired tumor growth and Ki67 immunoreactivity in xenografts.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>YAP1 is a potential novel prognostic marker in patients with ACC. Its deregulation contributes to adrenocortical tumorigenesis partially through crosstalk between Hippo\/YAP1 and Wnt\/\u03b2-catenin pathways. YAP1 inhibition is a new antitumor target.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf013","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:00:28Z","timestamp":1736449228000},"page":"2530-2542","source":"Crossref","is-referenced-by-count":4,"title":["YAP1 Is a Prognostic Marker and Its Inhibition Reduces Tumor Progression in Adrenocortical Tumors"],"prefix":"10.1210","volume":"110","author":[{"given":"Candy C B","family":"More","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto, SP 14049-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Bueno","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto, SP 14049-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar A O","family":"Rojas","sequence":"additional","affiliation":[{"name":"Hematology Division, LIM31, Medical School, University of Sao Paulo , Ribeirao Preto, SP 01246-903 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica F","family":"Stecchini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto, SP 14049-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando S","family":"Ramalho","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto, SP 14049-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia R","family":"Brandalise","sequence":"additional","affiliation":[{"name":"Boldrini Children's Center, State University of Campinas , Campinas, SP 13083-210 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izilda A","family":"Cardinalli","sequence":"additional","affiliation":[{"name":"Boldrini Children's Center, State University of Campinas , Campinas, SP 13083-210 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Andres","family":"Yunes","sequence":"additional","affiliation":[{"name":"Boldrini Children's Center, State University of Campinas , Campinas, SP 13083-210 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Junqueira","sequence":"additional","affiliation":[{"name":"Boldrini Children's Center, State University of Campinas , Campinas, SP 13083-210 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A","family":"Scrideli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics - Pediatric Oncology Division, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto, SP 14049-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto, SP 14049-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4778-8803","authenticated-orcid":false,"given":"Sonir R R","family":"Antonini","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo , Ribeirao Preto, SP 14049-900 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"issue":"5","key":"2025081215531014600_dgaf013-B1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jpedsurg.2013.02.017","article-title":"Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study","volume":"48","author":"McAteer","year":"2013","journal-title":"J Pediatr Surg"},{"issue":"4","key":"2025081215531014600_dgaf013-B2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"2025081215531014600_dgaf013-B3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"issue":"3","key":"2025081215531014600_dgaf013-B4","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1210\/jc.2014-3282","article-title":"Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma","volume":"100","author":"Juhlin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025081215531014600_dgaf013-B5","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1210\/jc.2011-0363","article-title":"Wnt\/\u03b2-catenin pathway deregulation in childhood adrenocortical tumors","volume":"96","author":"Leal","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025081215531014600_dgaf013-B6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/1078-0432.CCR-10-2006","article-title":"\u03b2-Catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma","volume":"17","author":"Gaujoux","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2025081215531014600_dgaf013-B7","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2018-01348","article-title":"Targeted molecular analysis in adrenocortical carcinomas: a strategy toward improved personalized prognostication","volume":"103","author":"Lippert","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025081215531014600_dgaf013-B8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4161\/cc.11.6.19453","article-title":"YAP oncogene overexpression supercharges colon cancer proliferation","volume":"11","author":"Avruch","year":"2012","journal-title":"Cell Cycle"},{"issue":"23","key":"2025081215531014600_dgaf013-B9","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1101\/gad.1824509","article-title":"YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation","volume":"23","author":"Fernandez-L","year":"2009","journal-title":"Genes Dev"},{"issue":"25","key":"2025081215531014600_dgaf013-B10","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/onc.2011.8","article-title":"The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene","volume":"30","author":"Zhang","year":"2011","journal-title":"Oncogene"},{"issue":"14","key":"2025081215531014600_dgaf013-B11","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev"},{"issue":"7","key":"2025081215531014600_dgaf013-B12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine","volume":"19","author":"Dey","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2025081215531014600_dgaf013-B13","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1038\/s41598-018-28928-3","article-title":"Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature","volume":"8","author":"Poma","year":"2018","journal-title":"Sci Rep"},{"issue":"51","key":"2025081215531014600_dgaf013-B14","doi-asserted-by":"crossref","first-page":"84634","DOI":"10.18632\/oncotarget.12382","article-title":"Unraveling the expression of the oncogene YAP1, a Wnt\/beta-catenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients","volume":"7","author":"Abduch","year":"2016","journal-title":"Oncotarget"},{"issue":"17","key":"2025081215531014600_dgaf013-B15","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/onc.2015.288","article-title":"YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells","volume":"35","author":"Hua","year":"2016","journal-title":"Oncogene"},{"issue":"33","key":"2025081215531014600_dgaf013-B16","doi-asserted-by":"crossref","first-page":"34658","DOI":"10.18632\/oncotarget.5778","article-title":"Wnt activated \u03b2-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells","volume":"6","author":"Park","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"2025081215531014600_dgaf013-B17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13046-017-0606-1","article-title":"\u03b2-catenin-mediated YAP signaling promotes human glioma growth","volume":"36","author":"Wang","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"7430","key":"2025081215531014600_dgaf013-B18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11693","article-title":"Restriction of intestinal stem cell expansion and the regenerative response by YAP","volume":"493","author":"Barry","year":"2013","journal-title":"Nature"},{"issue":"3","key":"2025081215531014600_dgaf013-B19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/\u03b2-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"issue":"12","key":"2025081215531014600_dgaf013-B20","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD\u2013YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev"},{"key":"2025081215531014600_dgaf013-B21","doi-asserted-by":"crossref","first-page":"557429","DOI":"10.3389\/fphar.2020.557429","article-title":"The role of photoactivated and non-photoactivated verteporfin on tumor","volume":"11","author":"Wei","year":"2020","journal-title":"Front Pharmacol"},{"issue":"11","key":"2025081215531014600_dgaf013-B22","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1210\/en.2017-00098","article-title":"Targeted disruption of YAP and TAZ impairs the maintenance of the adrenal cortex","volume":"158","author":"Levasseur","year":"2017","journal-title":"Endocrinology"},{"issue":"5","key":"2025081215531014600_dgaf013-B23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1530\/EJE-21-0879","article-title":"Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors","volume":"186","author":"Bueno","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2025081215531014600_dgaf013-B24","doi-asserted-by":"crossref","unstructured":"More C, Antonini SR. 2024. YAP1 is a prognostic marker and its inhibition reduces tumor progression in adrenocortical tumors [Internet]. Zenodo. doi:10.5281\/zenodo.14556125. Date of deposit 25 December 2024.","DOI":"10.1210\/clinem\/dgaf013"},{"issue":"2","key":"2025081215531014600_dgaf013-B25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/0008-5472.CAN-06-3767","article-title":"Gene expression profiling of childhood adrenocortical tumors","volume":"67","author":"West","year":"2007","journal-title":"Cancer Res"},{"issue":"24","key":"2025081215531014600_dgaf013-B26","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1158\/1078-0432.CCR-15-2738","article-title":"Prognostic significance of major histocompatibility complex class II expression in pediatric adrenocortical tumors: a St. Jude and Children's Oncology Group Study","volume":"22","author":"Pinto","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"43","key":"2025081215531014600_dgaf013-B27","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025081215531014600_dgaf013-B28","first-page":"PO.19.00163","article-title":"DNA methylation profiling reveals prognostically significant groups in pediatric adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry","volume":"3","author":"Clay","year":"2019","journal-title":"JCO Precis Oncol"},{"issue":"40","key":"2025081215531014600_dgaf013-B29","doi-asserted-by":"crossref","first-page":"43016","DOI":"10.18632\/oncotarget.5513","article-title":"Inhibition of the Tcf\/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis","volume":"6","author":"Leal","year":"2015","journal-title":"Oncotarget"},{"key":"2025081215531014600_dgaf013-B30","doi-asserted-by":"crossref","first-page":"111757","DOI":"10.1016\/j.mce.2022.111757","article-title":"Vitamin D receptor activation is a feasible therapeutic target to impair adrenocortical tumorigenesis","volume":"558","author":"Bueno","year":"2022","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2025081215531014600_dgaf013-B31","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1200\/JCO.2004.08.085","article-title":"Clinical and outcome characteristics of children with adrenocortical tumors: a report from the international pediatric adrenocortical tumor registry","volume":"22","author":"Michalkiewicz","year":"2004","journal-title":"J Clin Oncol"},{"issue":"7696","key":"2025081215531014600_dgaf013-B32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nature"},{"issue":"17","key":"2025081215531014600_dgaf013-B33","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of \u03b2-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res"},{"issue":"7","key":"2025081215531014600_dgaf013-B34","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.cell.2012.11.026","article-title":"\u03b2-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis","volume":"151","author":"Rosenbluh","year":"2012","journal-title":"Cell"},{"issue":"17","key":"2025081215531014600_dgaf013-B35","doi-asserted-by":"crossref","first-page":"28628","DOI":"10.18632\/oncotarget.15614","article-title":"Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells","volume":"8","author":"Dasari","year":"2017","journal-title":"Oncotarget"},{"issue":"24","key":"2025081215531014600_dgaf013-B36","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.3390\/cancers13246214","article-title":"The Hippo signaling pathway in cancer: a cell cycle perspective","volume":"13","author":"Xiao","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2025081215531014600_dgaf013-B37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2017.04.004","article-title":"Hippo signaling suppresses cell ploidy and tumorigenesis through Skp2","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"2025081215531014600_dgaf013-B38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","article-title":"YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response","volume":"158","author":"Azzolin","year":"2014","journal-title":"Cell"},{"issue":"2","key":"2025081215531014600_dgaf013-B39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41419-017-0244-8","article-title":"YAP triggers the Wnt\/\u03b2-catenin signalling pathway and promotes enterocyte self-renewal, regeneration and tumorigenesis after DSS-induced injury","volume":"9","author":"Deng","year":"2018","journal-title":"Cell Death Dis"},{"issue":"8","key":"2025081215531014600_dgaf013-B40","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1158\/0008-5472.CAN-20-2801","article-title":"YAP and \u03b2-catenin cooperate to drive oncogenesis in basal breast cancer","volume":"81","author":"Quinn","year":"2021","journal-title":"Cancer Res"},{"issue":"3","key":"2025081215531014600_dgaf013-B41","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of \u03b2 catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"2025081215531014600_dgaf013-B42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.devcel.2013.08.013","article-title":"YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function","volume":"26","author":"Tsutsumi","year":"2013","journal-title":"Dev Cell"},{"issue":"5","key":"2025081215531014600_dgaf013-B43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/emboj.2011.487","article-title":"A molecular mechanism that links Hippo signalling to the inhibition of Wnt\/\u03b2-catenin signalling","volume":"31","author":"Imajo","year":"2012","journal-title":"EMBO J"},{"issue":"2","key":"2025081215531014600_dgaf013-B44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12020-017-1409-z","article-title":"Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?","volume":"58","author":"Bulzico","year":"2017","journal-title":"Endocrine"},{"issue":"22","key":"2025081215531014600_dgaf013-B45","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1200\/JCO.20.02871","article-title":"Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: the Children's Oncology Group ARAR0332 Protocol","volume":"39","author":"Rodriguez-Galindo","year":"2021","journal-title":"J Clin Oncol"},{"issue":"8","key":"2025081215531014600_dgaf013-B46","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/ijc.32667","article-title":"Verteporfin targeting YAP1\/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells","volume":"146","author":"Giraud","year":"2020","journal-title":"Int J Cancer"},{"issue":"58","key":"2025081215531014600_dgaf013-B47","doi-asserted-by":"crossref","first-page":"98887","DOI":"10.18632\/oncotarget.21946","article-title":"Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1","volume":"8","author":"Kang","year":"2017","journal-title":"Oncotarget"},{"issue":"397","key":"2025081215531014600_dgaf013-B48","doi-asserted-by":"crossref","first-page":"ra98","DOI":"10.1126\/scisignal.aac5418","article-title":"Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1","volume":"8","author":"Zhang","year":"2015","journal-title":"Sci Signal"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf013\/61398075\/dgaf013.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/2530\/61398075\/dgaf013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/2530\/61398075\/dgaf013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T19:53:27Z","timestamp":1755028407000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/9\/2530\/7950771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,1,10]]},"published-print":{"date-parts":[[2025,8,7]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf013","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,1,10]]}}}